CellaMedic Korea

CellaMedic Korea is a South Korean biotechnology company specializing in the development and commercialization of regenerative medicine products derived from placental extracts. The company's primary focus is on porcine placental extract (PPE), which is processed using proprietary enzyme hydrolysis technology to maintain high bioactivity and safety. CellaMedic Korea's products are utilized for treating menopausal symptoms, improving liver function, and promoting skin rejuvenation and anti-aging. The company has supported multiple clinical trials and academic collaborations, including research with Kyung Hee University, to validate the efficacy of its placental-derived therapies in women's health and regenerative medicine. Their portfolio targets unmet needs in the aging population through innovative biological modalities.